Not applicableStudy completedNCT04690205What this trial is testingHospital at Home at EOL in Heme MalignanciesWho this might be right forHematologic Malignancy Massachusetts General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT01572181What this trial is testingStudy of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning RegimensWho this might be right forHematologic Malignancy Nantes University Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03214666What this trial is testingGTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological MalignanciesWho this might be right forHigh-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more GT Biopharma, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00796068What this trial is testingTreosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more Fred Hutchinson Cancer Center 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03431090What this trial is testingHaploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and MyelodysplasiaWho this might be right forMyelodysplasiaHematologic Malignancy Nationwide Children's Hospital 20
Not applicableStudy completedNCT04826458What this trial is testingClinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in OncohematologyWho this might be right forCancerSolid TumorHematologic Malignancy+1 more Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 124
Early research (Phase 1)Looking for participantsNCT04318678What this trial is testingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)Who this might be right forAML/MDSB-ALLT-ALL+1 more St. Jude Children's Research Hospital 108
Testing effectiveness (Phase 2)UnknownNCT04582604What this trial is testingRuxolitinib and Decitabine for High Risk Hematological MalignanciesWho this might be right forPeripheral Blood Stem Cell Transplantation Chinese PLA General Hospital 60
Not applicableStudy completedNCT00666289What this trial is testingFamilial Myeloproliferative DisordersWho this might be right forPolycythemia VeraEssential ThrombocythemiaIdiopathic Myelofibrosis Icahn School of Medicine at Mount Sinai 17
Testing effectiveness (Phase 2)WithdrawnNCT04190433What this trial is testingAutophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialWho this might be right forBreast CarcinomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+1 more Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT05436418What this trial is testingThe Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationWho this might be right forPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation National Cancer Institute (NCI) 260
Not applicableLooking for participantsNCT06369389What this trial is testingReal-life Management of Patients Eligible for CAR-T Cell TherapyWho this might be right forHemopathy University Hospital, Toulouse 550
Testing effectiveness (Phase 2)Study completedNCT04975555What this trial is testingStudy to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyWho this might be right forCytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more University of Alabama at Birmingham 20
Early research (Phase 1)UnknownNCT05170568What this trial is testingPA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesWho this might be right forCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies PersonGen BioTherapeutics (Suzhou) Co., Ltd. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03983850What this trial is testingOptimizing PTCy Dose and TimingWho this might be right forGraft Versus Host DiseaseHematologic Neoplasms National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Study completedNCT00849147What this trial is testingBone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Who this might be right forPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more Medical College of Wisconsin 55
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417What this trial is testingBusulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWho this might be right forHematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more M.D. Anderson Cancer Center 204
Early research (Phase 1)Study completedNCT01351350What this trial is testingDose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid MalignanciesWho this might be right forAdvanced Solid MalignanciesHematologic Malignancies Millennium Pharmaceuticals, Inc. 68
Not applicableWithdrawnNCT03086252What this trial is testingPatient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot StudyWho this might be right forAnemiaAplastic AnemiaBone Marrow Failure+3 more Emory University